Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer
Open Access
- 1 October 2005
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 63 (2), 320-323
- https://doi.org/10.1016/j.ijrobp.2005.07.002
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer DatabaseJournal of the American College of Surgeons, 1999
- High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505International Journal of Radiation Oncology*Biology*Physics, 1991
- Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1JNCI Journal of the National Cancer Institute, 1988
- External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancerCancer, 1988
- Intraoperative and external beam irradiation ± 5-FU for locally advanced pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Randomized trial of intraoperative radiotherapy in resected carcinoma of the pancreasInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study groupCancer, 1981